GLENMARK
US: Glenmark Pharmaceuticals, BluePoint Laboratories Recall 135 Batches of Blood Pressure Capsules Over Cardiac Arrest Fear
FabiSpray: COVID-19 First Nasal Spray by Glenmark for Treating Adult Patients Launched in India
Glenmark Pharma Reports Revenue Growth of 26% and PAT Growth of 21% YoY for Q1 FY 2021-22
Nasal Spray for COVID-19 Treatment: Glenmark, Canada's SaNOtize to Manufacture, Market and Distribute Nitric Oxide Nasal Spray in India
Glenmark Announces Top-line Results from Phase 3 Clinical Trial of Favipiravir in Patients with Mild to Moderate COVID-19
Google Trends